Neurogenerative diseases result from progressive damage to cells and nervous system connections. The desire for less invasive diagnostics has continued to spur interest in blood-based biomarkers and furthered the use of imaging biomarkers as tools for research, such as hippocampal volume and PET imaging as tools for research. Other trending studies focus on the use of knockout models to isolate mutated genes to further characterize them. 

From polyclonal and monoclonal antibodies to Apo-E and amyloid precursor protein ELISA kits, to BACE1 and Alpha-synuclein recombinant proteins and biologicals including disease state plasma and serum, we offer a growing library of the research tools needed to push your work forward.